Didier Lapierre

1.2k total citations
4 papers, 245 citations indexed

About

Didier Lapierre is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Didier Lapierre has authored 4 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Virology and 2 papers in Immunology. Recurrent topics in Didier Lapierre's work include HIV Research and Treatment (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Viral Infections and Immunology Research (1 paper). Didier Lapierre is often cited by papers focused on HIV Research and Treatment (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Viral Infections and Immunology Research (1 paper). Didier Lapierre collaborates with scholars based in Belgium, United States and Netherlands. Didier Lapierre's co-authors include Jaime E. Hernández, Jane Yeo, Sara Hughes, Amy Cutrell, Lloyd Curtis, Mounir Ait‐Khaled, Cindy Brothers, Marie‐Ange Demoitié, Willem A. Hanekom and Philippe Moris and has published in prestigious journals such as Vaccine, JAIDS Journal of Acquired Immune Deficiency Syndromes and Human Vaccines.

In The Last Decade

Didier Lapierre

4 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Didier Lapierre Belgium	4	195	109	78	77	63	4	245
Leslie R. Cockerham United States	10	200 1.0×	105 1.0×	255 3.3×	137 1.8×	124 2.0×	11	403
S.F.L. van Lelyveld Netherlands	13	255 1.3×	111 1.0×	234 3.0×	68 0.9×	107 1.7×	28	395
Ornella Sortino United States	7	115 0.6×	63 0.6×	80 1.0×	67 0.9×	68 1.1×	11	264
José López-Aldeguer Spain	8	177 0.9×	62 0.6×	145 1.9×	20 0.3×	68 1.1×	13	244
Raquel Ron Spain	10	148 0.8×	40 0.4×	61 0.8×	25 0.3×	67 1.1×	24	261
Randall Tressler United States	7	219 1.1×	90 0.8×	239 3.1×	46 0.6×	75 1.2×	11	327
Lars N. Nielsen Denmark	6	275 1.4×	48 0.4×	80 1.0×	60 0.8×	233 3.7×	7	344
David Sahner United States	7	150 0.8×	53 0.5×	198 2.5×	101 1.3×	67 1.1×	10	285
M Johnson United Kingdom	7	213 1.1×	88 0.8×	231 3.0×	16 0.2×	134 2.1×	7	335
Liliana Elena Weimer Italy	8	144 0.7×	72 0.7×	134 1.7×	21 0.3×	45 0.7×	22	200

Countries citing papers authored by Didier Lapierre

Since Specialization

Citations

This map shows the geographic impact of Didier Lapierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Lapierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Lapierre more than expected).

Fields of papers citing papers by Didier Lapierre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Lapierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Lapierre. The network helps show where Didier Lapierre may publish in the future.

Co-authorship network of co-authors of Didier Lapierre

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Lapierre. A scholar is included among the top collaborators of Didier Lapierre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Lapierre. Didier Lapierre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Penn‐Nicholson, Adam, Hennie Geldenhuys, Wivine Burny, et al.. (2015). Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting. Vaccine. 33(32). 4025–4034. 92 indexed citations

2.

Vekemans, Johan, et al.. (2011). Pooled analysis of safety data from pediatric Phase II RTS,S/AS malaria candidate vaccine trials. Human Vaccines. 7(12). 1309–1316. 8 indexed citations

3.

Brothers, Cindy, Jaime E. Hernández, Amy Cutrell, et al.. (2009). Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(1). 20–28. 133 indexed citations

4.

Simón, Fernando, Anne Krivine, Min Z. Levine, et al.. (1993). Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection.. PubMed. 6(2). 201–7. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact